| Francisco Zornosa, MD | |
|
500 S Oakwood Rd, Oshkosh, WI 54904-7944 | |
| (920) 223-1000 | |
| Not Available |
| Full Name | Francisco Zornosa |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 34 Years |
| Location | 500 S Oakwood Rd, Oshkosh, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225070774 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gundersen Lutheran Medical Center | La crosse, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gundersen Lutheran Medical Center Inc | 2163331414 | 800 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced it has received approval through the European Mutual Recognition Procedure for an extension to the current indication for FOSRENOL(R) (lanthanum carbonate), paving the way to make the non-calcium, non-resin phosphate binder available throughout the EU to control hyperphosphataemia in chronic kidney disease (CKD) patients who are not on dialysis with a serum phosphorus level greather than or equal to 1.78mmol/L (5.5mg/dL).
With unsurpassed value and energy efficiency, the AIM LED provides 10 times the life and uses 55 percent less energy when compared to halogen light sources. Burton Medical Products, Inc. has developed a revolutionary diagnostic and examination light, the AIM LED, by combining the smart and versatile design of their existing AIM lights with the efficiency and longevity of an LED light source.
Women account for half of all cases of high blood pressure (hypertension) in the U.S., yet the majority of hypertension research focuses on men.
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced it will present a poster at the 74th Annual Scientific Meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP), to be held November 7-11, 2010 in Atlanta, Georgia.
A technique which revolutionizes cell culture by allowing the continuous production and collection of cells, has been developed by scientists at Newcastle University.
› Verified 7 days ago
| Entity Name | Ascension Medical Group-fox Valley Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730126392 PECOS PAC ID: 0244142420 Enrollment ID: O20031105000351 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced it has received approval through the European Mutual Recognition Procedure for an extension to the current indication for FOSRENOL(R) (lanthanum carbonate), paving the way to make the non-calcium, non-resin phosphate binder available throughout the EU to control hyperphosphataemia in chronic kidney disease (CKD) patients who are not on dialysis with a serum phosphorus level greather than or equal to 1.78mmol/L (5.5mg/dL).
With unsurpassed value and energy efficiency, the AIM LED provides 10 times the life and uses 55 percent less energy when compared to halogen light sources. Burton Medical Products, Inc. has developed a revolutionary diagnostic and examination light, the AIM LED, by combining the smart and versatile design of their existing AIM lights with the efficiency and longevity of an LED light source.
Women account for half of all cases of high blood pressure (hypertension) in the U.S., yet the majority of hypertension research focuses on men.
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced it will present a poster at the 74th Annual Scientific Meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP), to be held November 7-11, 2010 in Atlanta, Georgia.
A technique which revolutionizes cell culture by allowing the continuous production and collection of cells, has been developed by scientists at Newcastle University.
› Verified 7 days ago
| Entity Name | Gundersen Lutheran Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376593442 PECOS PAC ID: 2163331414 Enrollment ID: O20130619000254 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced it has received approval through the European Mutual Recognition Procedure for an extension to the current indication for FOSRENOL(R) (lanthanum carbonate), paving the way to make the non-calcium, non-resin phosphate binder available throughout the EU to control hyperphosphataemia in chronic kidney disease (CKD) patients who are not on dialysis with a serum phosphorus level greather than or equal to 1.78mmol/L (5.5mg/dL).
With unsurpassed value and energy efficiency, the AIM LED provides 10 times the life and uses 55 percent less energy when compared to halogen light sources. Burton Medical Products, Inc. has developed a revolutionary diagnostic and examination light, the AIM LED, by combining the smart and versatile design of their existing AIM lights with the efficiency and longevity of an LED light source.
Women account for half of all cases of high blood pressure (hypertension) in the U.S., yet the majority of hypertension research focuses on men.
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced it will present a poster at the 74th Annual Scientific Meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP), to be held November 7-11, 2010 in Atlanta, Georgia.
A technique which revolutionizes cell culture by allowing the continuous production and collection of cells, has been developed by scientists at Newcastle University.
› Verified 7 days ago
| Entity Name | Epsilon Kidney Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629705421 PECOS PAC ID: 0749654234 Enrollment ID: O20230420001195 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced it has received approval through the European Mutual Recognition Procedure for an extension to the current indication for FOSRENOL(R) (lanthanum carbonate), paving the way to make the non-calcium, non-resin phosphate binder available throughout the EU to control hyperphosphataemia in chronic kidney disease (CKD) patients who are not on dialysis with a serum phosphorus level greather than or equal to 1.78mmol/L (5.5mg/dL).
With unsurpassed value and energy efficiency, the AIM LED provides 10 times the life and uses 55 percent less energy when compared to halogen light sources. Burton Medical Products, Inc. has developed a revolutionary diagnostic and examination light, the AIM LED, by combining the smart and versatile design of their existing AIM lights with the efficiency and longevity of an LED light source.
Women account for half of all cases of high blood pressure (hypertension) in the U.S., yet the majority of hypertension research focuses on men.
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced it will present a poster at the 74th Annual Scientific Meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP), to be held November 7-11, 2010 in Atlanta, Georgia.
A technique which revolutionizes cell culture by allowing the continuous production and collection of cells, has been developed by scientists at Newcastle University.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Francisco Zornosa, MD 500 S Oakwood Rd, Oshkosh, WI 54904-7944 Ph: (920) 223-1000 | Francisco Zornosa, MD 500 S Oakwood Rd, Oshkosh, WI 54904-7944 Ph: (920) 223-1000 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced it has received approval through the European Mutual Recognition Procedure for an extension to the current indication for FOSRENOL(R) (lanthanum carbonate), paving the way to make the non-calcium, non-resin phosphate binder available throughout the EU to control hyperphosphataemia in chronic kidney disease (CKD) patients who are not on dialysis with a serum phosphorus level greather than or equal to 1.78mmol/L (5.5mg/dL).
With unsurpassed value and energy efficiency, the AIM LED provides 10 times the life and uses 55 percent less energy when compared to halogen light sources. Burton Medical Products, Inc. has developed a revolutionary diagnostic and examination light, the AIM LED, by combining the smart and versatile design of their existing AIM lights with the efficiency and longevity of an LED light source.
Women account for half of all cases of high blood pressure (hypertension) in the U.S., yet the majority of hypertension research focuses on men.
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced it will present a poster at the 74th Annual Scientific Meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP), to be held November 7-11, 2010 in Atlanta, Georgia.
A technique which revolutionizes cell culture by allowing the continuous production and collection of cells, has been developed by scientists at Newcastle University.
› Verified 7 days ago
Zahid N Dar, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-303-8700 | |
Dr. Brian A.w. Temple, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-303-8700 Fax: 920-303-8992 | |
Anita I Gheller-rigoni, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-456-5900 Fax: 920-456-5901 | |
Maye R Berroya, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-456-7408 | |
Dr. Benjamin Joseph Heinzen, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1855 S Koeller St, Oshkosh, WI 54902 Phone: 920-223-7100 | |
Mamoun B Al-nouri, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2700 W 9th Ave, Ste 106, Oshkosh, WI 54904 Phone: 920-236-1755 | |
Robert D. Geck, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-303-8700 |